ANIX
Anixa Biosciences IncNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
Factor tilt: Anti-Quality Micro Cap
$2.67-5.99%
Close Oct 13, 2026
- Market cap
- $90.84M
- 1 month
- -4.6%
- 3 months
- -23.7%
- 1 year
- -38.3%
- 52-week range
- $2.35$5.22
- Dividend
- No dividends on record
- Short interest
- 4.1% of float1.4M shares · settled Sep 30, 2026 · +28.0% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jul 31, 2026
- Revenue
- —
- Net income
- -$10.42M
- Free cash flow
- -$7.38M
- Book value
- $14.47M
- Total debt
- $174K
- P/E
- —
- Price / sales
- —
- Price / book
- 6.3×
- FCF yield
- -8.1%
- Net margin
- —
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if ANIX is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
9 top institutions tracked
as of 2026-Q2 (filed 2026-09-22)
Insider context
Sentiment: bullish
Last trade: buy 15 days ago
Red flags: 0
Largest 13-F holders · Q2 2026
62 filers reported a long position in ANIX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3.7M | 1.3M | +1.1% |
| UBS Group AG | $1.6M | 585.4K | +6.1% |
| Laird Norton Wetherby Trust Company, LLC | $1.6M | 578.7K | +2.2% |
| D.A. DAVIDSON & CO. | $1.5M | 539.3K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $1M | 359.2K | -1.5% |
| MARSHALL WACE, LLP | $919.3K | 328.3K | +89.6% |
| BlackRock, Inc. | $559.3K | 199.8K | +17.4% |
| VANGUARD FIDUCIARY TRUST CO | $538.6K | 192.4K | +0.7% |
| STATE STREET CORP | $445.3K | 159K | Unchanged |
| GSA CAPITAL PARTNERS LLP | $329K | 117.5K | +18.8% |
Get the Full Analysis for ANIX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.